APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rheumatoid Arthritis Stem Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rheumatoid Arthritis Stem Cell Therapy Market Analysis and Forecast 2026-2032

Report ID 174032790220 December 2025196 pages

Choose your research edition.

Industry ResearchRheumatoid Arthritis Stem Cell Therapy Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Rheumatoid Arthritis Stem Cell Therapy Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Rheumatoid Arthritis Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rheumatoid Arthritis Stem Cell Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Rheumatoid Arthritis Stem Cell Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Rheumatoid Arthritis Stem Cell Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Rheumatoid Arthritis Stem Cell Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rheumatoid Arthritis Stem Cell Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rheumatoid Arthritis Stem Cell Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rheumatoid Arthritis Stem Cell Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Rheumatoid Arthritis Stem Cell Therapy include International Stem Cell Corporation, Mesoblast, Regeneus, ReNeuron Group, Roslin Cells and Takeda, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Rheumatoid Arthritis Stem Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rheumatoid Arthritis Stem Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Rheumatoid Arthritis Stem Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rheumatoid Arthritis Stem Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rheumatoid Arthritis Stem Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Rheumatoid Arthritis Stem Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Rheumatoid Arthritis Stem Cell Therapy Segment by Company

International Stem Cell Corporation

Mesoblast

Regeneus

ReNeuron Group

Roslin Cells

Takeda

Rheumatoid Arthritis Stem Cell Therapy Segment by Type

Adipose Tissue Stem Cells

Allogeneic Mesenchymal Stem Cells

Bone Marrow Transplant

Rheumatoid Arthritis Stem Cell Therapy Segment by Application

Ambulatory Surgical Centers

Hospitals

Specialty Clinics

Rheumatoid Arthritis Stem Cell Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheumatoid Arthritis Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rheumatoid Arthritis Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheumatoid Arthritis Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Rheumatoid Arthritis Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Rheumatoid Arthritis Stem Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatoid Arthritis Stem Cell Therapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adipose Tissue Stem Cells Major Player Table 3. Allogeneic Mesenchymal Stem Cells Major Player Table 4. Bone Marrow Transplant Major Player Table 5. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Ambulatory Surgical Centers Major Player Table 7. Hospitals Major Player Table 8. Specialty Clinics Major Player Table 9. Rheumatoid Arthritis Stem Cell Therapy Industry Trends Table 10. Rheumatoid Arthritis Stem Cell Therapy Industry Drivers Table 11. Rheumatoid Arthritis Stem Cell Therapy Industry Opportunities and Challenges Table 12. Rheumatoid Arthritis Stem Cell Therapy Industry Restraints Table 13. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2021-2026) Table 16. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2027-2032) Table 18. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Players (2021-2026) Table 20. Global Rheumatoid Arthritis Stem Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Rheumatoid Arthritis Stem Cell Therapy Key Players Headquarters & Area Served Table 22. Global Rheumatoid Arthritis Stem Cell Therapy Players, Product Type & Application Table 23. Global Rheumatoid Arthritis Stem Cell Therapy Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Rheumatoid Arthritis Stem Cell Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2027-2032) Table 31. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2021-2026) Table 35. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2027-2032) Table 36. International Stem Cell Corporation Company Information Table 37. International Stem Cell Corporation Business Overview Table 38. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 40. International Stem Cell Corporation Recent Development Table 41. Mesoblast Company Information Table 42. Mesoblast Business Overview Table 43. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 45. Mesoblast Recent Development Table 46. Regeneus Company Information Table 47. Regeneus Business Overview Table 48. Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 50. Regeneus Recent Development Table 51. ReNeuron Group Company Information Table 52. ReNeuron Group Business Overview Table 53. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 55. ReNeuron Group Recent Development Table 56. Roslin Cells Company Information Table 57. Roslin Cells Business Overview Table 58. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 60. Roslin Cells Recent Development Table 61. Takeda Company Information Table 62. Takeda Business Overview Table 63. Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Takeda Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 65. Takeda Recent Development Table 66. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 72. North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 73. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 74. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 75. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 76. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 77. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 79. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 80. China Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 81. China Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 82. China Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 83. China Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 84. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 85. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 86. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 87. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Region (US$ Million) & (2021-2026) Table 90. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Region (US$ Million) & (2027-2032) Table 91. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026) & (US$ Million) Table 92. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032) & (US$ Million) Table 93. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026) & (US$ Million) Table 94. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032) & (US$ Million) Table 95. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026) & (US$ Million) Table 97. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (US$ Million) & (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Rheumatoid Arthritis Stem Cell Therapy Image Figure 2. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adipose Tissue Stem Cells Image Figure 5. Allogeneic Mesenchymal Stem Cells Image Figure 6. Bone Marrow Transplant Image Figure 7. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 9. Ambulatory Surgical Centers Image Figure 10. Hospitals Image Figure 11. Specialty Clinics Image Figure 12. Global Rheumatoid Arthritis Stem Cell Therapy Market Size (US$ Million) & (2021-2032) Figure 13. Global Rheumatoid Arthritis Stem Cell Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Rheumatoid Arthritis Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2021-2032) Figure 20. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2021-2032) Figure 23. North America Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 25. North America Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 26. North America Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 27. United States Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 32. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 33. Europe Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 34. Germany Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 44. China Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 45. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 47. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 48. Asia Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Region (2021-2032) Figure 49. Japan Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032) Figure 57. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032) Figure 58. SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Country (2021-2032) Figure 59. Brazil Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Rheumatoid Arthritis Stem Cell Therapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Adipose Tissue Stem Cells
  • Allogeneic Mesenchymal Stem Cells
  • Bone Marrow Transplant
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
Companies covered
  • International Stem Cell Corporation
  • Mesoblast
  • Regeneus
  • ReNeuron Group
  • Roslin Cells
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rheumatoid Arthritis Stem Cell Therapy Market by Type
  3. 1.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adipose Tissue Stem Cells
  5. 1.2.3 Allogeneic Mesenchymal Stem Cells
  6. 1.2.4 Bone Marrow Transplant
  7. 1.3 Rheumatoid Arthritis Stem Cell Therapy Market by Application
  8. 1.3.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Ambulatory Surgical Centers
  10. 1.3.3 Hospitals
  11. 1.3.4 Specialty Clinics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Rheumatoid Arthritis Stem Cell Therapy Market Dynamics
  1. 2.1 Rheumatoid Arthritis Stem Cell Therapy Industry Trends
  2. 2.2 Rheumatoid Arthritis Stem Cell Therapy Industry Drivers
  3. 2.3 Rheumatoid Arthritis Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Rheumatoid Arthritis Stem Cell Therapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Perspective (2021-2032)
  2. 3.2 Global Rheumatoid Arthritis Stem Cell Therapy Growth Trends by Region
  3. 3.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Players
  2. 4.1.1 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Rheumatoid Arthritis Stem Cell Therapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rheumatoid Arthritis Stem Cell Therapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Rheumatoid Arthritis Stem Cell Therapy Key Players Headquarters & Area Served
  7. 4.4 Global Rheumatoid Arthritis Stem Cell Therapy Players, Product Type & Application
  8. 4.5 Global Rheumatoid Arthritis Stem Cell Therapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Rheumatoid Arthritis Stem Cell Therapy Market CR5 and HHI
  11. 4.6.3 2025 Rheumatoid Arthritis Stem Cell Therapy Tier 1, Tier 2, and Tier 3
5 Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
  1. 5.1 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2032)
  3. 5.3 Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2021-2032)
6 Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
  1. 6.1 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2032)
  3. 6.3 Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 International Stem Cell Corporation
  2. 7.1.1 International Stem Cell Corporation Company Information
  3. 7.1.2 International Stem Cell Corporation Business Overview
  4. 7.1.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  6. 7.1.5 International Stem Cell Corporation Recent Developments
  7. 7.2 Mesoblast
  8. 7.2.1 Mesoblast Company Information
  9. 7.2.2 Mesoblast Business Overview
  10. 7.2.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  12. 7.2.5 Mesoblast Recent Developments
  13. 7.3 Regeneus
  14. 7.3.1 Regeneus Company Information
  15. 7.3.2 Regeneus Business Overview
  16. 7.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  18. 7.3.5 Regeneus Recent Developments
  19. 7.4 ReNeuron Group
  20. 7.4.1 ReNeuron Group Company Information
  21. 7.4.2 ReNeuron Group Business Overview
  22. 7.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  24. 7.4.5 ReNeuron Group Recent Developments
  25. 7.5 Roslin Cells
  26. 7.5.1 Roslin Cells Company Information
  27. 7.5.2 Roslin Cells Business Overview
  28. 7.5.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  30. 7.5.5 Roslin Cells Recent Developments
  31. 7.6 Takeda
  32. 7.6.1 Takeda Company Information
  33. 7.6.2 Takeda Business Overview
  34. 7.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Takeda Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  36. 7.6.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Rheumatoid Arthritis Stem Cell Therapy Revenue (2021-2032)
  2. 8.2 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032)
  5. 8.3 North America Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032)
  9. 8.5 North America Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country
  11. 8.6.1 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue (2021-2032)
  2. 9.2 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032)
  5. 9.3 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032)
  9. 9.5 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country
  11. 9.6.1 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Rheumatoid Arthritis Stem Cell Therapy Revenue (2021-2032)
  2. 10.2 China Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2032)
  3. 10.2.1 China Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026)
  4. 10.2.2 China Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032)
  5. 10.3 China Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 10.4 China Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2032)
  7. 10.4.1 China Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026)
  8. 10.4.2 China Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032)
  9. 10.5 China Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue (2021-2032)
  2. 11.2 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032)
  5. 11.3 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032)
  9. 11.5 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Country
  11. 11.6.1 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue (2021-2032)
  2. 12.2 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country
  11. 12.6.1 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Rheumatoid Arthritis Stem Cell Therapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst